(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 10.8% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.07%.
Astrana Health's revenue in 2026 is $3,526,482,000.On average, 12 Wall Street analysts forecast ASTH's revenue for 2026 to be $226,430,718,080, with the lowest ASTH revenue forecast at $214,786,028,100, and the highest ASTH revenue forecast at $239,412,597,340. On average, 12 Wall Street analysts forecast ASTH's revenue for 2027 to be $248,940,070,960, with the lowest ASTH revenue forecast at $228,993,664,200, and the highest ASTH revenue forecast at $267,772,153,320.
In 2028, ASTH is forecast to generate $263,927,734,140 in revenue, with the lowest revenue forecast at $253,564,517,220 and the highest revenue forecast at $271,672,288,720.